4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-24-060559
Chief Technical Officer sold 3,984 shares at an average $38.47 ($153,259)
- Chief Technical Officer acquired 3,984 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shulman Joseph Chief Technical Officer | 2024-05-09 | Option exercise 10b5-1 | +3,984 | $6.80 | $27,091 | 4,014 | D |
| Shulman Joseph Chief Technical Officer | 2024-05-09 | Sale 10b5-1 | −3,484 | $38.38 | $133,708 | 530 | D |
| Shulman Joseph Chief Technical Officer | 2024-05-09 | Sale 10b5-1 | −500 | $39.10 | $19,551 | 30 | D |
| Derivatives | |||||||
| Shulman Joseph Chief Technical Officer | 2024-05-09 | Option exercise · Stock Option (right to buy) 10b5-1 | −3,984 | 31,875 | D | ||
| Open-market sales · 3,984 sh · avg $38.47 · $153,259 | |||||||
Loading xslF345X05/tm2414300-1_4seq1.xml…